Search Results 51-60 of 16054 for pharmacogenetics

  1. PREemptive Pharmacogenomic testing for prevention of Adverse drug REactions - Mayo Clinic

    About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...

  2. Matthew P. Goetz, M.D. - Doctors and Medical Staff - Mayo Clinic

    Chair2024 Scientific Program Subcommittee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular Therapeutics Section.

  3. Mayo Clinic researchers use AI, biomarkers to personalize rheumatoid arthritis treatment

    Data used in the study came from a collaboration between Mayo Clinic and the Pharmacogenetics of Methotrexate in Rheumatoid Arthritis (PAMERA) consortium, that ...

  4. Andres J. Acosta, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    The study of genetic polymorphisms associated with gastrointestinal traits and obesity therapy, known as pharmacogenetics and novel pharmacotherapeutics, are a ...

  5. Pharmacogenomics (PGx) results and clinical data for assessing current and future therapeutic relevance.

    The goal of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a group of patients in order ...

  6. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Patients in the Palliative Medicine Clinic to Assess Current and Future Therapeutic Relevance - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...

  7. Faculty and Staff - Pharmacogenomics - Mayo Clinic Research

    Faculty and staff of the Pharmacogenomics Lab of Richard Weinshilboum, M.D., at Mayo Clinic's campus in Rochester, Minnesota.

  8. Pharmacogenomics (PGx) Results and Clinical Data of Established Patients with Liver Disease to Assess Current and Future Therapeutic Relevance of PGx Testing - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing in established patients with ...

  9. PGY-2 Pharmacy Residency in Clinical Pharmacogenomics at Mayo Clinic - Department and Faculty

    Learn about the department and faculty of the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.

  10. Pharmacogenomics: RIGHT 10K Study - Center for Individualized Medicine - Mayo Clinic Research

    In the Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment (RIGHT 10K) Study, Mayo Clinic collaborated with Baylor College of ...